Acorah Software Products - Accounts Production 16.2.850 true true 30 September 2023 1 October 2022 false 1 October 2023 30 September 2024 30 September 2024 10819524 Dr Bessam Farjo Dr Nilofer Farjo Mr Eric Halioua Mr Paul Kemp Mr Vincent Ronfard HairClone Limited true iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 10819524 2023-09-30 10819524 2024-09-30 10819524 2023-10-01 2024-09-30 10819524 frs-core:CurrentFinancialInstruments 2024-09-30 10819524 frs-core:ShareCapital 2024-09-30 10819524 frs-bus:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 10819524 frs-bus:FilletedAccounts 2023-10-01 2024-09-30 10819524 frs-bus:SmallEntities 2023-10-01 2024-09-30 10819524 frs-bus:EntityHasNeverTraded 2023-10-01 2024-09-30 10819524 frs-bus:AuditExempt-NoAccountantsReport 2023-10-01 2024-09-30 10819524 frs-bus:SmallCompaniesRegimeForAccounts 2023-10-01 2024-09-30 10819524 1 2023-10-01 2024-09-30 10819524 frs-bus:Director1 2023-10-01 2024-09-30 10819524 frs-bus:Director2 2023-10-01 2024-09-30 10819524 frs-bus:Director3 2023-10-01 2024-09-30 10819524 frs-bus:Director4 2023-10-01 2024-09-30 10819524 frs-bus:Director5 2023-10-01 2024-09-30 10819524 frs-countries:EnglandWales 2023-10-01 2024-09-30 10819524 2022-09-30 10819524 2023-09-30 10819524 2022-10-01 2023-09-30 10819524 frs-core:CurrentFinancialInstruments 2023-09-30 10819524 frs-core:ShareCapital 2023-09-30
Registered number: 10819524
Hairclone Cell Therapy Limited
Financial Statements
For The Year Ended 30 September 2024
Corinthian Tax LLP
Contents
Page
Balance Sheet 1
Notes to the Financial Statements 2
Page 1
Balance Sheet
Registered number: 10819524
2024 2023
Notes £ £ £ £
CURRENT ASSETS
Debtors 4 1 1
1 1
NET CURRENT ASSETS (LIABILITIES) 1 1
TOTAL ASSETS LESS CURRENT LIABILITIES 1 1
NET ASSETS 1 1
CAPITAL AND RESERVES
Called up share capital 1 1
SHAREHOLDERS' FUNDS 1 1
For the year ending 30 September 2024 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr Paul Kemp
Director
22/01/2025
The notes on page 2 form part of these financial statements.
Page 1
Page 2
Notes to the Financial Statements
1. General Information
Hairclone Cell Therapy Limited is a private company, limited by shares, incorporated in England & Wales, registered number 10819524 . The registered office is 70 Quay Street, Manchester, M3 3EJ.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Registrar Filing Requirements
The company has taken advantage of Companies Act 2006 section 444(1) and opted not to file the profit and loss account, directors report, and notes to the financial statements relating to the profit and loss account.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 5 (2023: 5)
5 5
4. Debtors
2024 2023
£ £
Due within one year
Amounts owed by group undertakings 1 1
5. Related Party Transactions
Included in other debtors is an amount of £1 which relates to amounts due by the parent company.
6. Ultimate Controlling Party
The company's ultimate controlling party is HairClone Limited by virtue of his ownership of 100% of the issued share capital in the company.
Page 2